Apresentação sobre como lidar com NDMAs na indústria farmacêutica | Notícias

Soluções API

Dr. Reddy's API business supplies high-quality, affordable APIs to leading generic formulations manufacturers and is the preferred API partner for pharma companies in more than 100 countries.

R&D

Dr. Reddy’s supplies generic APIs to 80+ countries, excelling in R\&D across niche molecules and key therapies, with capabilities from lab to production in contained/non-contained APIs and advanced chemical processes.

Livro Branco

Dr. Reddy’s offers insightful whitepapers sharing expertise on APIs, formulations, regulatory trends, and industry innovations, helping global pharma partners gain knowledge, solve challenges, and drive faster, compliant product development.

Addressing NDMAs in Pharmaceuticals

Dr. Reddy’s API participated in an exclusive presentation entitled “Addressing NDMAs in Pharmaceuticals” at CPHI on NDMAs in Pharmaceuticals by our Executive Vice President and Head of API Regulatory affairs, E Sreedhar, and our VP and Head of Chemistry (API R&D), Rakeshwar Bandichhor.

Ver mais notícias